Vertex Announces Positive Phase III Data for Hepatitis Drug

Vertex Pharmaceuticals has released promising Phase III data for its experimental hepatitis C drug telaprevir, positioning the drug candidate for potential blockbuster status. The New York Times reports that about 75 percent of patients taking telaprevir in combination with existing hepatitis C drugs were...

Find Out Which Companies Are Presenting at OneMedForum New York 2010

OneMedPlace has announced the first 38 companies to be presenting at the OneMedForum New York 2010 investor conference on June 29-30. The conference theme is “Accessing New Sources of Capital,” with a focus on connecting promising private and microcap companies from the U.S. and Europe with leading U.S....

Putting a Common Sleep Disorder to Bed

Millions of Americans suffer from sleep apnea, a disorder in which the patient repeatedly stops breathing during sleep. Sleep apnea occurs when the tongue or throat muscles close off the airway during sleep, or the brain fails to properly signal the muscles that control breathing. Patients may stop...

Pharmaceutical Companies Eye India

On May 21, Abbott Laboratories announced that it would purchase Piramal Healthcare, a branded generics company based in India, for $3.72 billion. The deal will give Abbott a 7 percent market share in India. Abbott expects pharmaceutical sales in India, which are projected to reach $8 billion this year, to...

Not a Drop to Drink

As we brush our teeth, take our long showers, and drink our eight glasses a day, it’s easy to forget that nearly one billion people in the world don’t have access to clean water. Poor sanitation in developing countries often causes waste to wind up in the water supply. The water may become...

The Latest Cardiology News

With the cardio-centric EuroPCR conference fast approaching, now is a good time to note some of the latest developments in the cardiovascular space: Cameron Health has released positive clinical trial data on a unique therapy to prevent sudden cardiac arrest, a leading cause of death in the U.S. The S-ICD...

Biomaterials, Implants

The company is a medical device company that has developed a technological platform to carry out biomaterial surface modifications to medical implants that improves the utility of the implants. The use of medical implants can be met with several complications that include infection, blood clot formation, and...

Physiological Monitoring

The company is a medical device company that has developed a technological platform for the development of advanced physiological monitoring devices, including apparatuses for use in hospital’s intensive care unit. The company uses a combination of proprietary biomaterials with micro-analyzer platforms...